Fluvoxamine for COVID-19: A New Weapon in the Fight?

The antidepressant appears to have some ability to prevent worsening in outpatients with COVID-19

By virtually all metrics, vaccine development for COVID-19 has been an astonishing success. But when it comes to therapeutics, the picture is much more mixed. This means the tip of the spear of the battle against…

--

--

--

Medicine, science, statistics. Associate Professor of Medicine at Yale University. New book “How Medicine Works and When it Doesn’t” for pre-order now.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

More Data, Better Planning, Less Politics: Chapter 3

Coronavirus and Vitamin D: Correlation, Causation, and Confusion

Independent Risk Factor

Covid-19 Vaccine Success Hinges on More Than Skepticism

Relationship of vaccination recency to COVID-19 population transmission

Screen the Kids!

Coronavirus Antibodies Common After Infection — But Not Often Protective

The Coronavirus Case Fatality Rate is Not the Same as the Infection Fatality Rate

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
F. Perry Wilson, MD MSCE

F. Perry Wilson, MD MSCE

Medicine, science, statistics. Associate Professor of Medicine at Yale University. New book “How Medicine Works and When it Doesn’t” for pre-order now.

More from Medium

Petrol prices got you looking at EVs?

Squeaky ‘Clean’ Deception: How safe are your personal care products, really?

A range of health and beauty products in bottles and tubes displayed on a pale pink background.

We Need to Acknowledge Needles as a Reason for Vaccine Hesitancy

Bogatyrs — Archetypes of Modern Russian Aggression